MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene ExpressionJun Xie, Guangping Gao, Qing Xie et al.|Molecular Therapy|2010Cited by 168
Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)Willem Pieter Brouwer, Krzysztof Simon, M Voiculescu et al.|Hepatology|2014Cited by 165
Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 CountriesJin-Lin Hou, Seng Gee Lim, Wei Zhao et al.|Clinical Gastroenterology and Hepatology|2019Cited by 111
miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorderLei Fan, Jin Ren, Rongtao Lai et al.|Journal of Hepatology|2020Cited by 70
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label studyXiaoning Wu, Hong You, Yiwen Shi et al.|Expert Opinion on Biological Therapy|2018Cited by 44